Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenglei Gu

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Medicinal Chemistry|January 17, 2025
Insights into tumor-derived exosome inhibition in cancer therapyZiwei Tang, Cheng Chen, Chen Zhou, et al.
Scientific Reports|May 18, 2016
Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics DataZhe Zhang, Ke Huang, Chenglei Gu, et al.
Bioorganic & Medicinal Chemistry|January 14, 2023
Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agentsJichao Chen, Yiping Duan, Kan Yang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 16, 2018
Effect of Mst1 on Endometriosis Apoptosis and Migration: Role of Drp1-Related Mitochondrial Fission and Parkin-Required MitophagyQingdong Zhao, Mingxia Ye, Wen Yang, et al.
Oncotargets and Therapy|September 19, 2022
Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian CancerYawen Wu, Xiaoyan Zhang, Lian Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 13, 2026
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitorsMingxia Ye, Yawen Wu, Zexin Chen, et al.
Frontiers in Immunology|April 23, 2026
Favorable short-term survival in locally advanced cervical cancer with optimal pathological response after neoadjuvant chemoimmunotherapy: a real-world analysisLuyang Zhao, Qingzhi Zhai, Wenbo Zhang, et al.
Scientific Reports|April 6, 2026
Development, validation, and visualization of a novel nomogram for predicting clinical outcomes of postoperative cervical cancer patientsYanqi Liu, Jia You, Dandan Liu, et al.
The Journal of International Medical Research|October 29, 2020
Healing effects of a protein scaffold loaded with adipose-derived mesenchymal stem cells on radiation-induced vaginal injury in ratsMingxia Ye, Ling Yu, Yujia She, et al.
Peerj|October 7, 2024
Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer <i>via</i> next-generation sequencingJia Xu, Wen Yang, Xiufeng Xie, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Medicinal Chemistry|January 17, 2025
Insights into tumor-derived exosome inhibition in cancer therapyZiwei Tang, Cheng Chen, Chen Zhou, et al.
Scientific Reports|May 18, 2016
Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics DataZhe Zhang, Ke Huang, Chenglei Gu, et al.
Bioorganic & Medicinal Chemistry|January 14, 2023
Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agentsJichao Chen, Yiping Duan, Kan Yang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 16, 2018
Effect of Mst1 on Endometriosis Apoptosis and Migration: Role of Drp1-Related Mitochondrial Fission and Parkin-Required MitophagyQingdong Zhao, Mingxia Ye, Wen Yang, et al.
Oncotargets and Therapy|September 19, 2022
Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian CancerYawen Wu, Xiaoyan Zhang, Lian Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 13, 2026
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitorsMingxia Ye, Yawen Wu, Zexin Chen, et al.
Frontiers in Immunology|April 23, 2026
Favorable short-term survival in locally advanced cervical cancer with optimal pathological response after neoadjuvant chemoimmunotherapy: a real-world analysisLuyang Zhao, Qingzhi Zhai, Wenbo Zhang, et al.
Scientific Reports|April 6, 2026
Development, validation, and visualization of a novel nomogram for predicting clinical outcomes of postoperative cervical cancer patientsYanqi Liu, Jia You, Dandan Liu, et al.
The Journal of International Medical Research|October 29, 2020
Healing effects of a protein scaffold loaded with adipose-derived mesenchymal stem cells on radiation-induced vaginal injury in ratsMingxia Ye, Ling Yu, Yujia She, et al.
Peerj|October 7, 2024
Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer <i>via</i> next-generation sequencingJia Xu, Wen Yang, Xiufeng Xie, et al.
Pageof 4